Eloxx Pharmaceuticals, Inc. Financial Ratios — ELOX Stock

Profitability (USD)

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	06/30/2012	06/30/2013	06/30/2014	06/30/2015	06/30/2016	06/30/2017	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	-167.92	-193	-88.59	-95.2	-100.68	-228.24	-212.48	-146.83	-128.59	-148.9	-409.19	- -	- -	- -	- -
Return on Assets (%)	-65.15	-87.14	-45.63	-68.32	-57.47	-76.92	-138.52	-124.99	-92.78	-80.95	-186.35	-108.86	-149.37	-134.09	-145.4
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	100	- -	100	100	100	- -	- -	- -	- -	- -	- -	- -	- -	100	- -
EBITDA Margin (%)	-2,416.18	- -	-6,572.38	-9,982.48	-4,827.52	- -	- -	- -	- -	- -	- -	- -	- -	-36.23	- -
Operating Margin (%)	-2,545.2	- -	-6,922.04	-10,218.58	-4,952.04	- -	- -	- -	- -	- -	- -	- -	- -	-38.81	- -
Incremental Operating Margin (%)	- -	-252.05	- -	- -	- -	-2,095.25	- -	- -	- -	- -	- -	- -	- -	- -	62.43
Pretax Margin (%)	-2,533.07	- -	-9,225.23	-24,085.05	-11,930.57	- -	- -	- -	- -	- -	- -	- -	- -	-49.43	- -
Profit Margin (%)	-2,533.07	- -	-9,225.23	-24,085.05	-11,023.91	- -	- -	- -	- -	- -	- -	- -	- -	-49.43	- -
Net Income to Common Margin (%)	-3,345.93	- -	-13,854.43	-25,203.61	-11,262.78	- -	- -	- -	- -	- -	- -	- -	- -	-49.43	- -
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	24.29	12.35	33.41	4.44	2.12	6.42	10.18	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	-127.12	-169.15	-58.99	-90.97	-98.54	-213.58	-190.85	-146.83	-128.59	-148.9	-409.19	- -	- -	- -	- -

Credit (USD)

Credit Ratios API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	06/30/2012	06/30/2013	06/30/2014	06/30/2015	06/30/2016	06/30/2017	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	2	2	- -	- -	- -	- -	- -	- -	16	12	13	13	4	7	1
ST Debt	2	2	- -	- -	- -	- -	- -	- -	5	6	1	5	2	7	1
LT Debt	- -	- -	- -	- -	- -	- -	- -	- -	11	6	13	9	2	- -	- -
Total Debt/EBITDA	-0.46	-0.51	- -	- -	- -	-0.19	- -	- -	-0.32	-0.42	-0.21	-0.4	-0.24	-2.83	-0.16
Net Debt/EBITDA	-0.04	-0.14	0.93	0.45	0.22	-0.18	1.26	1.04	0.15	0.45	0.47	0.2	-0.16	-2.78	0.59
Total Debt/EBIT	-0.43	-0.48	- -	- -	- -	-0.19	- -	- -	-0.31	-0.41	-0.2	-0.39	-0.23	-2.64	-0.16
Net Debt/EBIT	-0.04	-0.13	0.88	0.44	0.22	-0.17	1.26	1.03	0.15	0.44	0.46	0.19	-0.16	-2.6	0.59
EBITDA to Interest Expense	-35.92	-36.05	-84.87	-2,705.77	-6,792.94	-7.91	-443.28	-6,679.29	-30.94	-20.49	-51.67	-17.3	-14.32	-2.01	-6.14
EBITDA-CapEx/Interest Expense	-39.26	-40.49	-92.98	-2,799.58	-6,792.94	-7.92	-448.79	-6,712.86	-30.96	-20.49	-51.75	-17.34	-14.32	-2.01	-6.14
EBIT to Interest Expense	-37.83	-38.51	-89.39	-2,769.76	-6,968.17	-8.08	-444.19	-6,710.14	-31.28	-20.89	-52.44	-17.66	-15.02	-2.16	-6.14
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	2	1	1	2	1	1	1
Common Equity/Total Assets	49.65	53.34	82.47	62.53	49.41	14.88	86.19	84.61	61.43	38.64	49.59	-50.47	-1,320.04	-817.71	-225.94
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	30.17	62.65	57.18	- -	- -	- -	- -
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	21.02	28.78	35.71	319.09	-8.66	- -	- -
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	18.54	24.21	28.36	41.15	94.28	- -	- -
Total Debt/Equity (%)	63.69	57.77	- -	- -	- -	46.73	- -	- -	43.53	117.66	60.12	-125.55	-17.55	-26.79	-8.4
Total Debt/Capital (%)	38.91	36.62	- -	- -	- -	31.85	- -	- -	30.33	54.06	37.55	491.34	-21.28	-36.6	-9.17
Total Debt/Total Assets (%)	31.62	30.81	- -	- -	- -	6.97	- -	- -	26.74	45.46	29.81	63.36	231.66	219.09	18.98
Net Debt to Equity	5.73	15.45	-22.23	-27.28	-17.78	42.92	-112.58	-113.27	-21.14	-127.6	-135.24	62.57	-11.93	-26.32	31.79
Net Debt/Capital (%)	5.42	13.38	-28.59	-37.51	-21.62	30.03	894.68	853.49	-25.96	543.65	471.01	40.47	-13.64	-35.73	24.12
EBITDA	-5	-4	-7	-7	-4	-2	-19	-47	-50	-29	-65	-34	-16	-2	-6
EBITDA-CapEx	-5	-5	-7	-8	-4	-2	-19	-47	-50	-29	-65	-34	-16	-2	-6
Operating Income (Loss)	-5	-5	-7	-8	-4	-2	-19	-47	-51	-29	-66	-34	-17	-2	-6

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	06/30/2012	06/30/2013	06/30/2014	06/30/2015	06/30/2016	06/30/2017	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	0.63	0.5	3.35	4.28	2.2	0.01	7.03	6.23	4.77	2.51	4.25	0.83	0.05	- -	0.28
Current Ratio	1.12	1.1	3.96	4.79	2.66	0.1	7.16	6.45	4.89	2.63	4.37	0.87	0.07	0.11	0.31
Quick Ratio	0.63	0.5	3.37	4.28	2.2	0.01	7.03	6.23	4.77	2.51	4.25	0.83	0.05	0.1	0.28
CFO/Avg Current Liab	-1.36	-1.22	-1.93	-5.64	-6.41	-1.23	-5.14	-5.59	-4.02	-2.6	-3.54	-1.93	-0.63	-0.19	-0.28
Common Equity/Total Assets	49.65	53.34	82.47	62.53	49.41	14.88	86.19	84.61	61.43	38.64	49.59	-50.47	-1,320.04	-817.71	-225.94
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	30.17	62.65	57.18	- -	- -	- -	- -
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	21.02	28.78	35.71	319.09	-8.66	- -	- -
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	18.54	24.21	28.36	41.15	94.28	- -	- -
Total Debt/Equity (%)	63.69	57.77	- -	- -	- -	46.73	- -	- -	43.53	117.66	60.12	-125.55	-17.55	-26.79	-8.4
Total Debt/Capital (%)	38.91	36.62	- -	- -	- -	31.85	- -	- -	30.33	54.06	37.55	491.34	-21.28	-36.6	-9.17
Total Debt/Total Assets (%)	31.62	30.81	- -	- -	- -	6.97	- -	- -	26.74	45.46	29.81	63.36	231.66	219.09	18.98
CFO/Total Liabilities	-125.25	-117.84	-83.29	-100.3	-78.8	-38.7	-465.53	-401.78	-173.27	-173.36	-153.82	-100.2	-58.99	-17.26	-36.83
CFO/CapEx	-9.74	-7.38	-7.76	-28.29	- -	-770.04	-67.24	-133.48	-984.78	- -	-393.27	-482.5	- -	- -	- -
Altman's Z-Score	-30.74	-33.58	-18.4	-43.16	-153.89	-523.12	-0.21	-1.42	-4.44	-11.48	-11.18	-23.72	-286.47	-148.99	-86.59

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	06/30/2012	06/30/2013	06/30/2014	06/30/2015	06/30/2016	06/30/2017	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	- -	4.64	3.48	- -	- -	- -	- -	- -	- -	- -	- -	- -	5.39	- -
Days Sales Outstanding	- -	- -	78.72	104.96	- -	- -	- -	- -	- -	- -	- -	- -	- -	67.7	- -
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	06/30/2012	06/30/2013	06/30/2014	06/30/2015	06/30/2016	06/30/2017	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	2	1	4	2	- -	1	20	39	27	15	6	- -	- -	- -	- -
- Cash & Cash Equivalents	2	2	6	3	1	- -	24	49	22	25	42	19	1	- -	5
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	2	2	- -	- -	- -	- -	- -	- -	16	12	13	13	4	7	1
Enterprise Value	2	1	-3	-2	- -	1	-4	-9	-14	2	-23	-5	3	6	-4
Total Capital	6	6	27	12	5	1	21	43	52	22	36	3	-19	-18	-11
Total Debt/Capital (%)	38.91	36.62	- -	- -	- -	31.85	- -	- -	30.33	54.06	37.55	491.34	-21.28	-36.6	-9.17
Total Debt / EV	1.11	1.82	- -	- -	- -	0.37	- -	- -	-1.14	6.4	-0.58	-2.45	1.25	1.02	-0.26
EV/Sales	9.89	- -	92.21	140.1	48.83	- -	- -	- -	- -	- -	- -	- -	- -	1.01	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	2	1	4	1	- -	1	4	35	25	14	5	- -	- -	- -	- -
Diluted Enterprise Value	2	1	-3	-2	- -	1	-20	-13	19	2	-24	-5	3	6	-4
EV per Share	18,666.31	4,666.65	1,347.18	583.09	144.17	329.17	126.69	420.06	251.42	20.6	11.93	- -	11.35	- -	- -
TTM Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	6	- -
TTM EBITDA	-5	-4	-7	-7	-4	-2	-19	-47	-50	-29	-65	-34	-16	-2	-6
TTM Operating Income	-5	-5	-7	-8	-4	-2	-19	-47	-51	-29	-66	-34	-17	-2	-6
TTM Cash Flow to Firm	-4	-4	-5	-7	-4	-2	-16	-31	-38	-27	-34	-30	-13	-4	-5
TTM Free Cash Flow to Firm	-4	-3	-4	-7	-4	-2	-16	-31	-38	-27	-34	-30	-13	-4	-5

Multiples (USD)

Valuation Multiples API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	06/30/2012	06/30/2013	06/30/2014	06/30/2015	06/30/2016	06/30/2017	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	-0.45	-0.18	-0.83	-0.18	-0.11	-0.3	-0.23	-1.14	-0.65	-0.51	-0.13	-0.01	-0.02	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	2	1	-3	-2	- -	1	-4	-9	-14	2	-23	-5	3	6	-4
Low Price	12,800	1,600	1,600	408	120	64	128	250	115	57.6	22.8	1.7	0.4	- -	- -
EV/Sales	9.89	- -	92.21	140.1	48.83	- -	- -	- -	- -	- -	- -	- -	- -	1.01	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	-0.3	-0.43	-0.36	-0.08	-0.1	-0.07	-0.1	-0.81	-0.59	-0.34	-0.2	-0.07	-0.06	-0.06	- -
Price/Earnings High	-0.39	-0.95	-0.64	-0.2	-0.22	-0.13	-0.17	-1.54	-1	-0.86	-0.47	-0.16	-0.15	-0.15	-0.14
Price/Earnings Low	-0.2	-0.06	-0.18	-0.04	-0.03	-0.03	-0.06	-0.39	-0.2	-0.15	-0.05	-0.01	-0.01	- -	- -
Price/Book Value	0.52	0.16	0.13	0.13	0.09	0.82	0.94	0.91	0.74	1.42	0.25	-0.03	-0.01	- -	- -
Price/Book Value Average	0.58	0.8	0.18	0.16	0.19	0.62	0.61	0.99	0.87	1.15	0.74	-0.23	-0.05	- -	- -
Price/Book Value High	0.76	1.74	0.32	0.4	0.4	1.16	1.03	1.87	1.48	2.91	1.75	-0.55	-0.13	- -	-0.03
Price/Book Value Low	0.39	0.11	0.09	0.07	0.06	0.24	0.37	0.47	0.29	0.51	0.2	-0.03	- -	- -	- -
Price/Tangible Book Value	30.19	2.82	2.19	-0.49	-0.12	-0.15	0.94	0.91	0.74	1.42	0.25	-0.03	-0.01	- -	- -
Price/Tangible Book Value Average	33.72	13.81	3.08	-0.58	-0.24	-0.12	0.61	0.99	0.87	1.15	0.74	-0.23	-0.05	- -	- -
Price/Tangible Book Value High	44.56	30.08	5.48	-1.46	-0.52	-0.22	1.03	1.87	1.48	2.91	1.75	-0.55	-0.13	- -	-0.03
Price/Tangible Book Value Low	23	1.88	1.57	-0.26	-0.08	-0.05	0.37	0.47	0.29	0.51	0.2	-0.03	- -	- -	- -
Price/Sales	8.9	- -	35.24	16.77	5.42	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales Average	9.95	- -	49.47	20.02	11.18	- -	- -	- -	- -	- -	- -	- -	- -	0.03	- -
Price/Sales High	13.14	- -	88.09	50.32	24.38	- -	- -	- -	- -	- -	- -	- -	- -	0.07	- -
Price/Sales Low	6.78	- -	25.17	8.91	3.69	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Cash Flow	-0.41	-0.16	-0.72	-0.17	-0.11	-0.3	-0.23	-1.13	-0.65	-0.51	-0.13	-0.01	-0.02	- -	- -
Price/Cash Flow Average	-0.45	-0.78	-1.02	-0.2	-0.23	-0.22	-0.15	-1.22	-0.76	-0.42	-0.38	-0.08	-0.07	-0.04	- -
Price/Cash Flow High	-0.6	-1.69	-1.81	-0.51	-0.5	-0.42	-0.25	-2.31	-1.3	-1.06	-0.9	-0.18	-0.18	-0.1	-0.13
Price/Cash Flow Low	-0.31	-0.11	-0.52	-0.09	-0.08	-0.09	-0.09	-0.59	-0.25	-0.19	-0.1	-0.01	-0.01	- -	- -
Price/Free Cash Flow Average	-0.51	-0.9	-1.17	-0.21	-0.23	-0.22	-0.15	-1.23	-0.76	-0.42	-0.39	-0.08	-0.07	-0.04	- -
Price/Free Cash Flow High	-0.67	-1.96	-2.08	-0.53	-0.5	-0.42	-0.25	-2.33	-1.3	-1.06	-0.91	-0.18	-0.18	-0.1	-0.13
Price/Free Cash Flow Low	-0.34	-0.12	-0.59	-0.09	-0.08	-0.09	-0.09	-0.59	-0.25	-0.19	-0.1	-0.01	-0.01	- -	- -
EV/Sales Average	10.94	- -	154.14	175.8	0.49	- -	- -	- -	- -	- -	- -	- -	- -	1.01	- -
EV/Sales High	14.13	- -	26.97	21.03	13.81	- -	- -	- -	- -	- -	- -	- -	- -	1.01	- -
EV/Sales Low	7.77	- -	48.41	53.6	29.87	- -	- -	- -	- -	- -	- -	- -	- -	1.01	- -
EV/EBITDA Average	-0.45	-0.84	0.18	0.18	-0.01	-0.44	0.58	0.13	-0.5	0.03	0.19	0.1	-0.25	-2.78	0.59
EV/EBITDA High	-0.58	-1.67	-0.41	-0.21	-0.29	-0.66	0.11	-0.68	-0.94	-0.59	-0.16	- -	-0.36	-2.78	0.54
EV/EBITDA Low	-0.32	-0.23	0.55	0.33	0.15	-0.28	0.84	0.6	-0.07	0.26	0.37	0.16	-0.18	-2.78	0.59
EV/EBIT Average	-0.43	-0.79	0.17	0.18	-0.01	-0.43	0.58	0.13	-0.49	0.03	0.18	0.1	-0.23	-2.6	0.59
EV/EBIT High	-0.56	-1.57	-0.39	-0.21	-0.28	-0.65	0.11	-0.67	-0.93	-0.58	-0.16	- -	-0.34	-2.6	0.54
EV/EBIT Low	-0.31	-0.22	0.52	0.32	0.14	-0.27	0.84	0.6	-0.07	0.25	0.37	0.16	-0.17	-2.6	0.59
Last Price	16,800	2,400	2,240	768	176	216	320	480	294	159	28.4	1.82	1.2	- -	- -
High Price	24,800	25,600	5,600	2,304	792	304	352	984	590	326	199	29.6	10.9	1.39	0.75
Enterprise Value Average	2	4	-1	-1	- -	1	-11	-6	25	-1	-12	-3	4	6	-4
Enterprise Value High	3	7	3	2	1	1	-2	32	47	17	10	- -	6	6	-3
Enterprise Value Low	2	1	-4	-2	-1	1	-16	-28	4	-7	-24	-5	3	6	-4

Shares Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1
Basic Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1
Revenue per Share	1,886.79	- -	63.57	45.79	32.48	- -	- -	- -	- -	- -	- -	- -	- -	18.61	- -
EBITDA per Share	-45,588.38	-16,638.22	-4,178.25	-4,570.73	-1,568.05	-795.5	-1,685.47	-634.23	-577.94	-316.54	-409.15	-171.24	-70.52	-6.74	-5.74
Operating Income per Share	-48,022.56	-17,776.32	-4,400.53	-4,678.84	-1,608.5	-812.21	-1,688.92	-637.16	-584.4	-322.8	-415.19	-174.77	-73.98	-7.22	-5.74
Basic EPS, GAAP	-63,130.75	-27,075.74	-8,807.65	-11,540.12	-3,658.33	-2,348.09	-2,088.43	-640.07	-588.09	-379.16	-419.65	-183.13	-72.98	-9.2	-5.34
Basic EPS from Cont Ops	-47,793.71	-23,730.78	-5,864.74	-11,027.95	-3,580.74	-2,197.26	-1,875.85	-640.07	-588.09	-379.16	-419.65	-183.13	-72.98	-9.2	-5.34
Diluted EPS, GAAP	-63,130.75	-27,075.74	-8,807.65	-11,540.12	-3,658.33	-2,348.09	-2,088.43	-640.07	-588.09	-379.16	-419.65	-183.13	-72.98	-9.2	-5.34
Diluted EPS from Cont Ops	-47,793.71	-23,730.78	-5,864.74	-11,027.95	-3,580.74	-2,197.26	-1,875.85	-640.07	-588.09	-379.16	-419.65	-183.13	-72.98	-9.2	-5.34
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-41,377.82	-15,126.46	-3,094.81	-4,483.94	-1,592.12	-729.76	-1,409.05	-425.49	-455.35	-308.86	-220.12	-161.7	-61.37	-13.8	-5.64
Free Cash Flow per Basic Share	-45,627.78	-17,177.01	-3,493.87	-4,642.42	-1,592.12	-730.71	-1,430.01	-428.68	-455.81	-308.86	-220.68	-162.04	-61.37	-13.8	-5.64
Cash & Equivalents per Share	18,880.42	6,210.44	3,885.15	1,564.82	348.14	10.01	384.4	596.39	618.56	270.29	214.63	97.53	4.07	- -	10.99
Book Value per Share	32,575.3	14,674.65	17,476.11	5,735.54	1,957.19	262.09	341.43	526.52	398.04	112.09	113.66	-54.13	-81.02	- -	-27.34
Tangible Book Value per Share	556.51	851.02	1,022.34	-1,576.03	-1,520.69	-1,395.53	341.43	526.52	398.04	112.09	113.66	-54.13	-81.02	- -	-27.34

Eloxx Pharmaceuticals, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)